Global Central Nervous System Biomarkers Market 2023-2029 | |
Central Nervous System (CNS) biomarkers are biological indicators that can be measured in blood, cerebrospinal fluid or brain tissue to provide information about the function and structure of the central nervous system. Such biomarkers have been increasingly used in clinical research and diagnosis of various neurological disorders characterized by damage to the CNS, such as Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and traumatic brain injury, and aid in understanding disease progression or identifying potential therapeutic targets. The Global Central Nervous System Biomarkers Market is expected to increase by USD 3.2 billion, at a compound annual growth rate (CAGR) of 8.48% from 2023 to 2029, according to the latest edition of the Global Central Nervous System Biomarkers Market Report. | |
| Related Link: Click here to visit item owner's website (0 hit) | |
| Target State: All States Target City : Navi Mumbai Last Update : May 12, 2023 2:11 AM Number of Views: 76 | Item Owner : vidhya Contact Email: Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |